RARE
Ultragenyx Pharmaceutical Inc.
+0.60 (+4.66%)13.48USD1.6M成交股數1.3B市值–本益比(近四季)1.9股價營收比+28.1%營收年增(近四季)2026-11-03下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 5 · 340K · 3 |
| 其中 10b5-1 計畫賣出 | 4 筆 |
| 近 180 天 買進 · 賣出金額 | 0.00 · 915K |
| 近 180 天 淨額 | −915K |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-15 | 09-15 | Huizenga Theodore Alan | SVP, Chief Accounting Officer | S 公開市場賣出(10b5-1) | 1.3K | 13.57 | 17K | 67.9K | SEC |
| 2026-09-03 | 09-08 | Huizenga Theodore Alan | SVP, Chief Accounting Officer | S 公開市場賣出 | 161 | 13.99 | 2K | 69.1K | SEC |
| 2026-08-03 | 08-04 | Parschauer Karah Herdman | EVP and Chief Legal Officer | S 公開市場賣出(10b5-1) | 1.9K | 24.92 | 47K | 92.6K | SEC |
| 2026-08-03 | 08-04 | Horn Howard | Chief Financial Officer | S 公開市場賣出(10b5-1) | 4.7K | 24.92 | 117K | 96.3K | SEC |
| 2026-07-01 | 07-06 | Horn Howard | Chief Financial Officer | S 公開市場賣出(10b5-1) | 4.7K | 33.13 | 156K | 101K | SEC |
| 2026-06-15 | 06-15 | Sanders Corazon (Corsee) D. | Director | S 公開市場賣出 | 2.0K | 25.05 | 50K | 21.1K | SEC |
| 2026-06-15 | 06-15 | Parschauer Karah Herdman | EVP and Chief Legal Officer | S 公開市場賣出(10b5-1) | 1.9K | 24.62 | 47K | 94.5K | SEC |
| 2026-06-01 | 06-01 | Horn Howard | Chief Financial Officer | S 公開市場賣出(10b5-1) | 4.7K | 23.77 | 111K | 106K | SEC |
| 2026-05-18 | 05-18 | SULIMAN SHEHNAAZ | Director | S 公開市場賣出(10b5-1) | 5.7K | 25.12 | 144K | 28.0K | SEC |
| 2026-05-14 | 05-18 | Sanders Corazon (Corsee) D. | Director | A 獲配股票 | 7.8K | – | – | 23.1K | SEC |
| 2026-05-14 | 05-18 | Fust Matthew K | Director | A 獲配股票 | 7.8K | – | – | 33.7K | SEC |
| 2026-05-14 | 05-18 | NARACHI MICHAEL | Director | A 獲配股票 | 7.8K | – | – | 40.4K | SEC |
| 2026-05-14 | 05-18 | SULIMAN SHEHNAAZ | Director | A 獲配股票 | 7.8K | – | – | 33.7K | SEC |
| 2026-05-14 | 05-18 | Ray Amrit | Director | A 獲配股票 | 7.8K | – | – | 31.1K | SEC |
| 2026-05-14 | 05-18 | Dunsire Deborah | Director | A 獲配股票 | 7.8K | – | – | 38.6K | SEC |
| 2026-05-14 | 05-18 | WELCH DANIEL G | Director | A 獲配股票 | 7.8K | – | – | 40.4K | SEC |
| 2026-05-05 | 05-06 | Crombez Eric | EVP and Chief Medical Officer | S 公開市場賣出 | 344 | 24.96 | 9K | 111K | SEC |
| 2026-05-01 | 05-04 | Horn Howard | Chief Financial Officer | S 公開市場賣出(10b5-1) | 4.7K | 24.90 | 117K | 110K | SEC |
| 2026-04-22 | 04-24 | Huizenga Theodore Alan | SVP, Chief Accounting Officer | A 獲配股票 | 20.2K | – | – | 68.9K | SEC |
| 2026-04-16 | 04-20 | Horn Howard | Chief Financial Officer | A 獲配股票 | 34.7K | – | – | 115K | SEC |
| 2026-04-16 | 04-20 | KAKKIS EMIL D | President & CEO | A 獲配股票 | 76.7K | – | – | 736K | SEC |
| 2026-04-16 | 04-20 | Huang Dennis Karl | See Remarks | A 獲配股票 | 23.1K | – | – | 148K | SEC |
| 2026-04-16 | 04-20 | Pinion John Richard | See Remarks | A 獲配股票 | 23.1K | – | – | 133K | SEC |
| 2026-04-16 | 04-20 | Parschauer Karah Herdman | EVP and Chief Legal Officer | A 獲配股票 | 28.9K | – | – | 95.7K | SEC |
| 2026-04-16 | 04-20 | Harris Erik | EVP & Chief Commercial Officer | A 獲配股票 | 28.9K | – | – | 118K | SEC |
| 2026-04-16 | 04-20 | Crombez Eric | EVP and Chief Medical Officer | A 獲配股票 | 34.7K | – | – | 111K | SEC |
| 2026-04-01 | 04-02 | Horn Howard | Chief Financial Officer | S 公開市場賣出(10b5-1) | 4.7K | 20.97 | 98K | 80.4K | SEC |
| 2026-03-10 | 03-10 | Parschauer Karah Herdman | EVP and Chief Legal Officer | S 公開市場賣出 | 3.5K | 22.67 | 80K | 66.8K | SEC |
| 2026-03-06 | 03-10 | Parschauer Karah Herdman | EVP and Chief Legal Officer | S 公開市場賣出 | 6.0K | 21.40 | 129K | 70.3K | SEC |
| 2026-03-03 | 03-03 | Horn Howard | Chief Financial Officer | S 公開市場賣出(10b5-1) | 1.6K | 22.40 | 37K | 85.0K | SEC |
| 2026-03-02 | 03-03 | Huang Dennis Karl | See Remarks | F 繳稅扣股 | 999 | 23.39 | 23K | 125K | SEC |
| 2026-03-02 | 03-03 | Harris Erik | EVP & Chief Commercial Officer | S 公開市場賣出 | 10.5K | 22.80 | 240K | 89.5K | SEC |
| 2026-03-02 | 03-03 | KAKKIS EMIL D | President & CEO | S 公開市場賣出 | 54.4K | 22.80 | 1.2M | 659K | SEC |
| 2026-03-02 | 03-03 | Parschauer Karah Herdman | EVP and Chief Legal Officer | S 公開市場賣出 | 8.1K | 22.80 | 185K | 76.3K | SEC |
| 2026-03-02 | 03-03 | Pinion John Richard | See Remarks | S 公開市場賣出 | 10.0K | 22.80 | 229K | 110K | SEC |
| 2026-03-02 | 03-03 | Huizenga Theodore Alan | SVP, Chief Accounting Officer | S 公開市場賣出 | 1.6K | 22.80 | 37K | 48.7K | SEC |
| 2026-03-02 | 03-03 | Horn Howard | Chief Financial Officer | S 公開市場賣出(10b5-1) | 3.1K | 22.54 | 70K | 86.7K | SEC |
| 2026-03-02 | 03-03 | Huizenga Theodore Alan | SVP, Chief Accounting Officer | F 繳稅扣股 | 148 | 23.39 | 3K | 50.3K | SEC |
| 2026-03-02 | 03-03 | Horn Howard | Chief Financial Officer | S 公開市場賣出(10b5-1) | 5.3K | 22.80 | 121K | 89.8K | SEC |
| 2026-03-02 | 03-03 | Crombez Eric | EVP and Chief Medical Officer | S 公開市場賣出 | 7.0K | 22.80 | 160K | 76.3K | SEC |
| 2026-03-01 | 03-03 | Huang Dennis Karl | See Remarks | A 獲配股票 | 11.1K | – | – | 126K | SEC |
| 2026-03-01 | 03-03 | Pinion John Richard | See Remarks | A 獲配股票 | 11.1K | – | – | 120K | SEC |
| 2026-03-01 | 03-03 | Harris Erik | EVP & Chief Commercial Officer | A 獲配股票 | 11.6K | – | – | 99.5K | SEC |
| 2026-03-01 | 03-03 | KAKKIS EMIL D | President & CEO | A 獲配股票 | 71.2K | – | – | 713K | SEC |
| 2026-03-01 | 03-03 | Parschauer Karah Herdman | EVP and Chief Legal Officer | A 獲配股票 | 11.1K | – | – | 84.4K | SEC |
| 2026-03-01 | 03-03 | Crombez Eric | EVP and Chief Medical Officer | A 獲配股票 | 11.6K | – | – | 83.2K | SEC |
| 2026-03-01 | 03-03 | Horn Howard | Chief Financial Officer | A 獲配股票 | 6.1K | – | – | 95.1K | SEC |
| 2026-02-02 | 02-03 | Horn Howard | Chief Financial Officer | S 公開市場賣出(10b5-1) | 3.1K | 23.56 | 72K | 88.9K | SEC |
| 2026-01-02 | 01-05 | Horn Howard | Chief Financial Officer | S 公開市場賣出(10b5-1) | 3.1K | 22.84 | 72K | 92.0K | SEC |
| 2025-12-29 | 12-30 | Huizenga Theodore Alan | SVP, Chief Accounting Officer | S 公開市場賣出 | 85 | 34.38 | 3K | 50.5K | SEC |
| 2025-12-10 | 12-11 | Horn Howard | Chief Financial Officer | S 公開市場賣出(10b5-1) | 3.1K | 36.38 | 112K | 95.1K | SEC |
| 2025-10-13 | 10-14 | Horn Howard | Chief Financial Officer | S 公開市場賣出 | 7.9K | 31.51 | 250K | 98.2K | SEC |
| 2025-09-18 | 09-19 | Huizenga Theodore Alan | SVP, Chief Accounting Officer | S 公開市場賣出 | 64 | 29.17 | 2K | 50.2K | SEC |
| 2025-09-12 | 09-12 | Parschauer Karah Herdman | EVP and Chief Legal Officer | S 公開市場賣出 | 2.5K | 31.17 | 76K | 73.3K | SEC |
| 2025-09-05 | 09-08 | Huizenga Theodore Alan | SVP, Chief Accounting Officer | S 公開市場賣出 | 84 | 31.39 | 3K | 50.3K | SEC |
| 2025-06-20 | 06-23 | Sanders Corazon (Corsee) D. | Director | S 公開市場賣出(10b5-1) | 2.4K | 37.39 | 90K | 15.3K | SEC |
| 2025-05-15 | 05-19 | WELCH DANIEL G | Director | A 獲配股票 | 5.7K | – | – | 32.7K | SEC |
| 2025-05-15 | 05-19 | Sanders Corazon (Corsee) D. | Director | A 獲配股票 | 5.7K | – | – | 17.7K | SEC |
| 2025-05-15 | 05-19 | NARACHI MICHAEL | Director | A 獲配股票 | 5.7K | – | – | 32.7K | SEC |
| 2025-05-15 | 05-19 | Dunsire Deborah | Director | A 獲配股票 | 5.7K | – | – | 30.8K | SEC |
| 2025-05-15 | 05-19 | Ray Amrit | Director | A 獲配股票 | 5.7K | – | – | 23.4K | SEC |
| 2025-05-15 | 05-19 | SULIMAN SHEHNAAZ | Director | A 獲配股票 | 5.7K | – | – | 25.9K | SEC |
| 2025-05-15 | 05-19 | Fust Matthew K | Director | A 獲配股票 | 5.7K | – | – | 25.9K | SEC |
| 2025-05-05 | 05-05 | Crombez Eric | EVP and Chief Medical Officer | S 公開市場賣出 | 520 | 39.24 | 20K | 71.5K | SEC |
| 2025-04-21 | 05-05 | Crombez Eric | EVP and Chief Medical Officer | S 公開市場賣出 | 242 | 35.11 | 8K | 71.7K | SEC |
| 2025-03-06 | 03-10 | Horn Howard | Chief Financial Officer | S 公開市場賣出 | 1.8K | 40.40 | 72K | 106K | SEC |
| 2025-03-03 | 03-04 | Pinion John Richard | See Remarks | F 繳稅扣股 | 31 | 42.92 | 1K | 108K | SEC |
| 2025-03-03 | 03-04 | Pinion John Richard | See Remarks | S 公開市場賣出 | 14.4K | 42.10 | 608K | 108K | SEC |
| 2025-03-03 | 03-04 | Crombez Eric | EVP and Chief Medical Officer | S 公開市場賣出 | 8.9K | 42.10 | 377K | 71.9K | SEC |
| 2025-03-03 | 03-04 | Huang Dennis Karl | See Remarks | F 繳稅扣股 | 1.3K | 42.92 | 58K | 115K | SEC |
| 2025-03-03 | 03-04 | Huizenga Theodore Alan | SVP, Chief Accounting Officer | F 繳稅扣股 | 141 | 42.92 | 6K | 50.1K | SEC |
| 2025-03-03 | 03-04 | KAKKIS EMIL D | President & CEO | S 公開市場賣出(10b5-1) | 73.4K | 42.10 | 3.1M | 642K | SEC |
| 2025-03-03 | 03-04 | Kassberg Thomas Richard | CBO & EVP | S 公開市場賣出 | 6.0K | 42.10 | 254K | 265K | SEC |
| 2025-03-03 | 03-04 | Huizenga Theodore Alan | SVP, Chief Accounting Officer | S 公開市場賣出 | 967 | 42.10 | 41K | 50.3K | SEC |
| 2025-03-03 | 03-04 | Parschauer Karah Herdman | EVP and Chief Legal Officer | S 公開市場賣出 | 12.8K | 42.10 | 541K | 75.3K | SEC |
| 2025-03-03 | 03-04 | Kassberg Thomas Richard | CBO & EVP | F 繳稅扣股 | 508 | 42.92 | 22K | 265K | SEC |
| 2025-03-03 | 03-04 | Harris Erik | EVP & Chief Commercial Officer | S 公開市場賣出 | 15.1K | 42.10 | 636K | 87.9K | SEC |
| 2025-03-01 | 03-04 | KAKKIS EMIL D | President & CEO | A 獲配股票 | 107K | – | – | 715K | SEC |
| 2025-03-01 | 03-04 | KAKKIS EMIL D | President & CEO | A 獲配股票 | 43.3K | – | – | 608K | SEC |
| 2025-03-01 | 03-04 | Harris Erik | EVP & Chief Commercial Officer | A 獲配股票 | 18.4K | – | – | 102K | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| BlackRock, Inc. | 10.7M | 356M | 新進 | 新進 |
| RTW INVESTMENTS, LP | 7.8M | 260M | 新進 | 新進 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 6.8M | 227M | 新進 | 新進 |
| AQR CAPITAL MANAGEMENT LLC | 6.6M | 214M | 新進 | 新進 |
| STATE STREET CORP | 6.2M | 206M | 新進 | 新進 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.3M | 143M | 新進 | 新進 |
| Two Sigma TWO SIGMA INVESTMENTS, LP | 3.6M | 121M | 新進 | 新進 |
| SANDS CAPITAL MANAGEMENT, LLC | 3.2M | 105M | 新進 | 新進 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 2.9M | 98.2M | 新進 | 新進 |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 2.8M | 95.1M | 新進 | 新進 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.6M | 86.1M | 新進 | 新進 |
| Bellevue Group AG | 2.0M | 66.2M | 新進 | 新進 |
| 德劭 D. E. Shaw & Co., Inc. | 1.7M | 57.8M | 新進 | 新進 |
| Sofinnova Investments, Inc. | 1.7M | 57.3M | 新進 | 新進 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1.6M | 52.8M | 新進 | 新進 |
| MPM BIOIMPACT LLC | 1.4M | 47.4M | 新進 | 新進 |
| MORGAN STANLEY | 1.3M | 44.2M | 新進 | 新進 |
| WELLINGTON MANAGEMENT GROUP LLP | 1.3M | 41.8M | 新進 | 新進 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 1.2M | 41.5M | 新進 | 新進 |
| BANK OF AMERICA CORP /DE/ | 1.1M | 38.3M | 新進 | 新進 |
| Candriam S.C.A. | 1.0M | 33.4M | 新進 | 新進 |
| Rock Springs Capital Management LP | 968K | 32.3M | 新進 | 新進 |
| Jefferies Financial Group Inc. | 930K | 31.0M | 新進 | 新進 |
| NORTHERN TRUST CORP | 920K | 30.7M | 新進 | 新進 |
| Eagle Health Investments LP | 884K | 29.5M | 新進 | 新進 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 310 +12 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 310 / 0 / 0 / 0 |
| 機構合計持股 · 佔流通股 | 107M · 100.0% |
| 合計季末市值 | 3.4B |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 17.1M |
|---|---|
| 與上期比 | +7.9% |
| 佔流通股數 | 17.39% |
| 日均成交量 | 2.1M |
| 回補天數 | 8.0 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 17.1M | +7.9% | 17.39% | 2.1M | 8.0 |
| 2026-08-14 | 15.9M | +6.2% | 16.12% | 2.0M | 7.8 |
| 2026-07-31 | 15.0M | +11.4% | 15.18% | 1.8M | 8.3 |
| 2026-07-15 | 13.4M | -17.2% | 13.63% | 1.9M | 6.9 |
| 2026-06-30 | 16.2M | +13.3% | 16.45% | 4.5M | 3.6 |
| 2026-06-15 | 14.3M | -2.7% | 14.52% | 1.6M | 8.9 |
| 2026-05-29 | 14.7M | +5.2% | 14.91% | 1.5M | 9.8 |
| 2026-05-15 | 14.0M | +2.3% | 14.18% | 1.7M | 8.2 |
| 2026-04-30 | 13.7M | +13.1% | 13.86% | 1.6M | 8.4 |
| 2026-04-15 | 12.1M | +5.9% | 12.26% | 1.7M | 7.1 |
| 2026-03-31 | 11.4M | +14.9% | 11.58% | 2.4M | 4.8 |
| 2026-03-13 | 9.9M | +3.5% | 10.07% | 2.1M | 4.8 |
| 2026-02-27 | 9.6M | -2.7% | 9.73% | 1.8M | 5.4 |
| 2026-02-13 | 9.9M | +8.4% | 10.00% | 2.5M | 3.9 |
| 2026-01-30 | 9.1M | +2.6% | 9.23% | 2.4M | 3.9 |
| 2026-01-15 | 8.9M | +10.5% | 8.99% | 3.3M | 2.7 |
| 2025-12-31 | 8.0M | -6.8% | 8.13% | 4.3M | 1.9 |
| 2025-12-15 | 8.6M | -3.0% | 8.72% | 1.5M | 5.7 |
| 2025-11-28 | 8.9M | +13.3% | 9.00% | 1.2M | 7.2 |
| 2025-11-14 | 7.8M | +9.6% | 7.94% | 1.5M | 5.3 |
| 2025-10-31 | 7.1M | -17.8% | 7.25% | 1.3M | 5.6 |
| 2025-10-15 | 8.7M | +13.6% | 8.82% | 1.4M | 6.2 |
| 2025-09-30 | 7.7M | -3.7% | 7.76% | 2.0M | 3.9 |
| 2025-09-15 | 7.9M | -4.5% | 8.06% | 1.5M | 5.2 |
| 2025-08-29 | 8.3M | -1.0% | 8.44% | 1.2M | 6.8 |
| 2025-08-15 | 8.4M | +10.0% | 8.53% | 1.7M | 4.9 |